Kairos Pharma Ltd. (KAPA)
0.8334
-0.03
(-3.00%)
USD |
NYAM |
Dec 10, 11:56
Kairos Pharma Market Cap: 17.35M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 19.76M |
| AIM ImmunoTech, Inc. | 1.116M |
| IGC Pharma, Inc. | 31.58M |
| NovaBay Pharmaceuticals, Inc. | 265.88M |
| Protalix Biotherapeutics, Inc. | 142.35M |
Market Cap Related Metrics
| PEG Ratio | -0.0660 |
| Price to Book Value | 2.264 |
| Price | 0.8334 |
| Earnings Yield | -36.31% |
| PEGY Ratio | -0.0660 |